Biosenic SA [BIOS] vs European Medical [ALEMS] Detailed Stock Comparison
Biosenic SA
Euronext
Loading...
European Medical
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Biosenic SA wins in 5 metrics, European Medical wins in 10 metrics, with 0 ties. European Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Biosenic SA | European Medical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 0.00 | 35.38 | Biosenic SA |
| Price-to-Book Ratio | N/A | 1.88 | N/A |
| Debt-to-Equity Ratio | -1.18 | 191.98 | Biosenic SA |
| PEG Ratio | -0.05 | N/A | N/A |
| EV/EBITDA | -7.49 | 26.42 | Biosenic SA |
| Profit Margin (TTM) | -279.17% | 1.14% | European Medical |
| Operating Margin (TTM) | -17.33% | 3.24% | European Medical |
| EBITDA Margin (TTM) | N/A | 3.24% | N/A |
| Return on Equity | 126.75% | 5.40% | Biosenic SA |
| Return on Assets (TTM) | -22.77% | 1.70% | European Medical |
| Free Cash Flow (TTM) | $-3.47M | $-1.02M | European Medical |
| 1-Year Return | -80.00% | -36.40% | European Medical |
| Price-to-Sales Ratio (TTM) | 0.61 | 0.41 | European Medical |
| Enterprise Value | $26.64M | $34.74M | European Medical |
| EV/Revenue Ratio | 10.00 | 0.73 | European Medical |
| Revenue per Share (TTM) | $0 | $11 | European Medical |
| Earnings per Share (Diluted) | $-0.04 | $0.13 | European Medical |
| Beta (Stock Volatility) | -2.55 | 0.52 | Biosenic SA |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Biosenic SA vs European Medical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Biosenic SA | -4.17% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| European Medical | 2.16% | 2.17% | 6.82% | -14.55% | -25.98% | -21.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Biosenic SA | -80.00% | -98.25% | -99.73% | -99.94% | -98.97% | -98.97% |
| European Medical | -36.40% | -89.73% | -92.10% | -99.80% | -99.80% | -99.80% |
Performance & Financial Health Analysis: Biosenic SA vs European Medical
| Metric | BIOS | ALEMS |
|---|---|---|
| Market Information | ||
| Market Cap | €1.63M | €19.47M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 1,060,958 | 150 |
| 90 Day Avg. Volume | 1,893,712 | 98 |
| Last Close | €0.00 | €4.70 |
| 52 Week Range | €0.00 - €0.02 | €4.20 - €7.53 |
| % from 52W High | -85.63% | -37.61% |
| All-Time High | €28.90 (Feb 09, 2015) | €2,956.45 (Feb 27, 2017) |
| % from All-Time High | N/A | -99.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 6.38% | 0.19% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | -2.79% | 0.01% |
| Operating Margin (TTM) | -0.17% | 0.03% |
| Return on Equity (TTM) | 1.27% | 0.05% |
| Debt to Equity (MRQ) | -1.18 | 191.98 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-0.08 | €2.44 |
| Cash per Share (MRQ) | €0.00 | €1.08 |
| Operating Cash Flow (TTM) | €-2,374,000 | €2.56M |
| Levered Free Cash Flow (TTM) | €-2,313,375 | €-3,446,375 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Biosenic SA vs European Medical
| Metric | BIOS | ALEMS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 0.00 | 35.38 |
| Forward P/E | -0.05 | N/A |
| PEG Ratio | -0.05 | N/A |
| Price to Sales (TTM) | 0.61 | 0.41 |
| Price to Book (MRQ) | N/A | 1.88 |
| Market Capitalization | ||
| Market Capitalization | €1.63M | €19.47M |
| Enterprise Value | €26.64M | €34.74M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 10.00 | 0.73 |
| Enterprise to EBITDA | -7.49 | 26.42 |
| Risk & Other Metrics | ||
| Beta | -2.55 | 0.52 |
| Book Value per Share (MRQ) | €-0.08 | €2.44 |
Financial Statements Comparison: Biosenic SA vs European Medical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | BIOS | ALEMS |
|---|---|---|
| Revenue/Sales | €0 | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | €2.43M | N/A |
| Operating Income (EBIT) | €-1.88M | N/A |
| EBITDA | €-1.79M | N/A |
| Pre-Tax Income | €-1.91M | N/A |
| Income Tax | €0 | N/A |
| Net Income (Profit) | €-1.91M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | BIOS | ALEMS |
|---|---|---|
| Cash & Equivalents | €117,000 | €4.58M |
| Total Current Assets | €1.85M | €34.21M |
| Total Current Liabilities | €15.84M | €21.34M |
| Long-Term Debt | €16.34M | €12.50M |
| Total Shareholders Equity | €-22.71M | €10.34M |
| Retained Earnings | €-34.89M | €547,000 |
| Property, Plant & Equipment | €56,000 | €5.96M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | BIOS | ALEMS |
|---|---|---|
| Operating Cash Flow | €-3.20M | N/A |
| Capital Expenditures | €-628,000 | N/A |
| Free Cash Flow | €-260,000 | N/A |
| Debt Repayment | €0 | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | BIOS | ALEMS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,060,958 | 150 |
| Average Daily Volume (90 Day) | 1,893,712 | 98 |
| Shares Outstanding | 163.18M | 4.23M |
| Float Shares | 223.08M | 490,512 |
| % Held by Insiders | 0.14% | 0.91% |
| % Held by Institutions | 0.02% | 0.00% |
Dividend Analysis & Yield Comparison: Biosenic SA vs European Medical
| Metric | BIOS | ALEMS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |